Back to results
RecruitingPhase 1

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

NCT05627960

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Maryland Greenebaum Comprehensive Cancer Center

Baltimore, Maryland, United States

Contact

Ginette Serrero, PhD/DSC.

(410)884-4100gserrero@agpharma.com
View on ClinicalTrials.gov
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies — TrialFind